Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 1
1990 1
1991 7
1992 6
1993 2
1994 1
1995 1
1996 1
1998 4
1999 2
2002 1
2003 5
2004 6
2005 5
2006 6
2007 3
2008 6
2009 1
2010 4
2011 5
2012 3
2013 7
2014 4
2015 13
2016 4
2017 5
2018 7
2019 5
2020 9
2021 6
2022 3
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Results by year

Filters applied: . Clear all
Page 1
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
Diabetic Retinopathy Clinical Research Network; Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW. Diabetic Retinopathy Clinical Research Network, et al. N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18. N Engl J Med. 2015. PMID: 25692915 Free PMC article. Clinical Trial.
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.
Jhaveri CD, Glassman AR, Ferris FL 3rd, Liu D, Maguire MG, Allen JB, Baker CW, Browning D, Cunningham MA, Friedman SM, Jampol LM, Marcus DM, Martin DF, Preston CM, Stockdale CR, Sun JK; DRCR Retina Network. Jhaveri CD, et al. N Engl J Med. 2022 Aug 25;387(8):692-703. doi: 10.1056/NEJMoa2204225. Epub 2022 Jul 14. N Engl J Med. 2022. PMID: 35833805 Free PMC article. Clinical Trial.
Introduction to hypersonic vitrectomy.
Blinder KJ, Awh CC, Tewari A, Garg SJ, Srivastava SK, Kolesnitchenko V. Blinder KJ, et al. Curr Opin Ophthalmol. 2019 May;30(3):133-137. doi: 10.1097/ICU.0000000000000563. Curr Opin Ophthalmol. 2019. PMID: 30883439 Review.
Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial.
Bressler NM, Beaulieu WT, Glassman AR, Blinder KJ, Bressler SB, Jampol LM, Melia M, Wells JA 3rd; Diabetic Retinopathy Clinical Research Network. Bressler NM, et al. Among authors: blinder kj. JAMA Ophthalmol. 2018 Mar 1;136(3):257-269. doi: 10.1001/jamaophthalmol.2017.6565. JAMA Ophthalmol. 2018. PMID: 29392288 Free PMC article. Clinical Trial.
Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab.
Witkin AJ, Hahn P, Murray TG, Arevalo JF, Blinder KJ, Choudhry N, Emerson GG, Goldberg RA, Kim SJ, Pearlman J, Schneider EW, Tabandeh H, Wong RW. Witkin AJ, et al. Among authors: blinder kj. J Vitreoretin Dis. 2020 Jul;4(4):269-279. doi: 10.1177/2474126420930863. Epub 2020 Jul 1. J Vitreoretin Dis. 2020. PMID: 32789284 Free PMC article.
Purtscher-Like Retinopathy in a Patient with COVID-19.
Bottini AR, Steinmetz S, Blinder KJ, Shah GK. Bottini AR, et al. Among authors: blinder kj. Case Rep Ophthalmol Med. 2021 Mar 20;2021:6661541. doi: 10.1155/2021/6661541. eCollection 2021. Case Rep Ophthalmol Med. 2021. PMID: 33859855 Free PMC article.
129 results